Reshape Lifesciences Stock Story
| RSLS Stock | USD 0.17 0.01 6.25% |
Slightly above 58% of ReShape Lifesciences' investor base is looking to short. The analysis of overall sentiment of trading ReShape Lifesciences stock suggests that many investors are alarmed at this time. ReShape Lifesciences' investor sentiment overview provides quick insight into current market opportunities from investing in ReShape Lifesciences. The current market sentiment, together with ReShape Lifesciences' historical and current headlines, can help investors time the market. In addition, many technical investors use ReShape Lifesciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
ReShape Lifesciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ReShape daily returns and investor perception about the current price of ReShape Lifesciences as well as its diversification or hedging effects on your existing portfolios.
ReShape |
Requested story not found. it has been either deleted or moved. View all stories for ReShape Lifesciences.
ReShape Lifesciences Latest Timeline
ReShape Lifesciences is listed for 0.17. The company has price-to-book ratio of 0.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. ReShape Lifesciences recorded a loss per share of 1.91. The entity last dividend was issued on the 25th of July 2019. The firm had 1:50 split on the 23rd of December 2022.Check out ReShape Lifesciences Hype Analysis, ReShape Lifesciences Correlation and ReShape Lifesciences Performance. For more information on how to buy ReShape Stock please use our How to Invest in ReShape Lifesciences guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for ReShape Stock analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is ReShape Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReShape Lifesciences. If investors know ReShape will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReShape Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Revenue Per Share 1.457 | Quarterly Revenue Growth (0.36) | Return On Assets (0.84) | Return On Equity (2.21) |
The market value of ReShape Lifesciences is measured differently than its book value, which is the value of ReShape that is recorded on the company's balance sheet. Investors also form their own opinion of ReShape Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is ReShape Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReShape Lifesciences' market value can be influenced by many factors that don't directly affect ReShape Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReShape Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ReShape Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReShape Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.